Your Content Goes Here
Lonzas new technical note introduces a flexible, high-throughput workflow for generating and characterizing macrophage subtypesnave, M1, and M2from cryopreserved PBMCs or CD14_monocytes. This workflow is ideal for supporting drug discovery, immunotoxicology, and disease modeling by enabling researchers to replicate immune responses with precision. Key features include discussion on:
Dual Starting Materials : Discover differences between PBMCs or CD14_monocytes to match your research needs.
Validated Polarization : M1 and M2 macrophages are reliably produced using IFN-_/LPS or IL-4/IL-10, respectively.
Live-Cell Phagocytosis Assay : Real-time imaging quantifies functional activity across macrophage types.
Phenotypic Confirmation : Surface markers and cytokine profiles confirm accurate polarization and This article is ideal for researchers studying immune modulation, inflammation, and therapeutic response.
Not all macrophages are created equalLonza helps you choose the right path. Access the technical note: [formidable id="78"]
次のステップへ進む
Explore Suppliers
関連する専門知識を持つ信頼できるパートナーを探す
Review Capabilities
サービス、経験、実績を比較する
Start Your Project
つながり、協業を始める
.png)
.jpg)
.png)
.avif)
.avif)
